Impact of Dried Moringa Oleifera Leaves in Enhancing Hemoglobin Status

Anemia, Iron Deficiency Clinical Trial

Official title:

Impact of Dried Moringa Oleifera Leaves as Value Added Supplement in Enhancing Hemoglobin Status of Reproductive Aged Females of Low Socio-economic Group

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03514472
• Other study ID #: MMunir
• Status: Completed
• Phase: N/A
• Start date: January 2013
• Est. completion date: April 2014

Study information

• Verified date: May 2018
• Source: Kinnaird College for Women
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This research project is aimed at combating the nutritional deficiencies (Iron deficiency anemia) of reproductive aged females belonging to the underprivileged group of the society. Since anemia is one of the causes of still child-birth, preterm and low birth weight babies causing cognitive disabilities during the later years of life, So, it needs to be treated on priority bases.

Description:

Mal-nutrition is a significant problem in the developing world, with serious consequences for human health and socio-economic development. It is estimated that over 43% women of reproductive age suffer from anemia. In Pakistan, about 35% non-pregnant and 51% pregnant women are suffering from anemia. Prevention and control against anemia rely on iron supplementation and food fortification on large scale. Both these methods are not affordable and feasible for poor people. Previous studies have shown that about 97% females do not meet their iron requirements. The possible reason to this can be iron losses from body including menstruation. To overcome these problems, culturally accepted, inexpensive and modified recipes were used to supply iron with addition of Moringa oleifera leaves (rich and cheap source of iron). In the study 34 of ages between 13-30 years were selected (excluding pregnant and lactating women) and were intervened with value added supplement " Moringa oleifera" for a period of three months. These recipes were made part of the diet by giving a dose of three meals per day on regular basis. Each recipe contained about 15 g of Dried Moringa powder. After the intervention, out of total 34, 3 females achieved normal Hb level of 12 g/dl. Overall, 94% cases of the study showed improvement of 1.8 g/dl (on average) in Hb level after intervention. There was a significant increase in blood Hb level (p<0.000) and both the var5iables were strongly and positively correlated (0.928). Variables of age and levels of education were weakly but significantly related to each other (p<0.001) in improving Hb after intervention.

Females with higher levels of education showed better response towards intervention.

After intervention with Moringa oleifera, an average increase of 1.5 g/dl in Hb was observed in the entire population whereas, members of Group B (ages above 18) showed more increase of 14.96% in their Hb level as compared to members of Group A (ages below 18) showing an increase of 12.96% in Hb level.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 34
• Est. completion date: April 2014
• Est. primary completion date: December 2013
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 13 Years to 30 Years

Eligibility

Inclusion Criteria:

• Reproductive aged females (13-30 years)

Exclusion Criteria:

• pregnant and Lactating women

Related Conditions & MeSH terms

• Anemia, Iron Deficiency
• Anemia, Iron-Deficiency

Intervention

Dietary Supplement:
• Dried Moringa oleifera leaves

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Kinnaird College for Women

References & Publications (1)

ACC/SCN. (1998). Challenges for the 21 st Century: A Gender perspective on the Nutrition through the Life Cycle. Geneva: ACC/SCN Secretariat c/o WHO. Anwar, F., & Bhanger, M. I. (2003). Analytical characterization of Moringa oleifera seed oil grown in temperate regions of Pakistan . Journal of Agricultural and Food Chemistry, 51, 6558-6563.

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Improvement in Hemoglobin status	Comparison of Hb levels pre and post intervention	3 months
Secondary	Changes in BMI	Changes in BMI after improvement in Hb status	5 months